Wordt geladen...
Severe hypercalcemia and hypernatremia in a patient treated with canagliflozin
Drugs that inhibit the sodium-glucose co-transporter-2 (SGLT2) are an exciting novel, insulin-independent treatment for diabetes that block glucose reabsorption from the proximal tubules of the kidney, leading to increased glucose excretion and lower blood glucose levels. Inhibition of SGLT2 activit...
Bewaard in:
| Gepubliceerd in: | Endocrinol Diabetes Metab Case Rep |
|---|---|
| Hoofdauteurs: | , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Bioscientifica Ltd
2015
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4501313/ https://ncbi.nlm.nih.gov/pubmed/26191411 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1530/EDM-15-0042 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|